IHH Healthcare’s net income doubles net income to $152.1m in 3Q23

The company attributed the higher net income to higher patient volumes and improved case mix.

SGX-listed IHH Healthcare more than doubled its net income in 3Q23, earning RM532.1m ($152.1m).

The company attributed its higher net income to higher patient volumes and improved case mix.

In the same period, IHH Healthcare's revenue and earnings before interest, taxes, depreciation, and amortisation (EBITDA) grew double digits.

In 3Q23, the company’s revenue rose 27% YoY to RM5.8b ($1.7b), whilst its EBITDA jumped 42% YoY to RM1.4b ($400m).

Following its stellar performance in 3Q23, the company paid its shareholders an Interim cash dividend of 3.5 sen ($0.010) per ordinary share on 27 October.

1 SGD = 3.50 RM